Mon, Dec 22, 2014, 1:35 AM EST - U.S. Markets open in 7 hrs 55 mins


% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

  • nokoincidenz nokoincidenz Feb 7, 2010 5:08 PM Flag

    What is the most valuable thing about Cytori?

    Can another company come in and copy their technology?

    I see the most valuable things being the celution system, patent protection and multiple applications.

    If all of the applications are so good and I believe they are, how long will it take another company to hop on board? Can another company leapfrog and use Cytori's many years of research or does another company have to start from ground Zero? Does the FDA let other companies use data from Cytori to create their own products?

    I also wonder how good the patents are, whether the products or applications can be tweaked to bypass them?

    Finally, we all have seen numbers on the size of these markets. Like the breast reconstruction patients were 3 mil in the US, 3 mil in Europe and I forget how many in Asia, I think it was around 3 mil as well. I am curious what these markets actually translate into? I would think the numbers would be huge just for this application let alone some of the other applications.

    The heart application could be mind boggling!!!!!!!!!!

    This is why it is hard for me to think about people actually shorting a company with the potential Cytori has.

    I was really suprised the other day with the heart news the SP actually ended down. Was all this caused by institutional selling to get into more cash?

    Maybe I am impatient, but these are my thoughts.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.5059-0.0061(-1.19%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.